Exosome Technologies Market Research Report 2021 – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2031 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Exosome Technologies Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031” report has been added to ResearchAndMarkets.com’s offering.

The report on the global exosome technologies market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2031.

The report provides revenue of the global exosome technologies market for the period 2017-2031, considering 2020 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global exosome technologies market during the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global exosome technologies market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various phenomenon in the global exosome technologies market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global exosome technologies market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global exosome technologies market.

The report delves into the competitive landscape of the global exosome technologies market. Key players operating in the global exosome technologies market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global exosome technologies market that have been profiled in this report.

Key Topics Covered:

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary: Global Exosome Technologies Market

4. Market Overview

4.1. Introduction

4.1.1. Exosome Type Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.4. Global Exosome Technologies Market Analysis and Forecast, 2015-2031

5. Key Insights

5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

5.2. Key Industry Events (mergers, acquisitions, partnerships, etc.)

5.3. Pipeline Analysis

5.4. Technological Advancement

5.5. Licensing deals (IP portfolio/patent/status of – Codiak, Ciloa SAS, Evox, and ExonanoRNA LLC)

6. Global Exosome Technologies Market Analysis and Forecast, by Exosome Type

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Market Value Forecast, by Exosome Type, 2015-2031

6.3.1. Loaded Cargo

6.3.1.1. Peptide

6.3.1.2. siRNA

6.3.1.3. mRNA

6.3.1.4. miRNA

6.3.1.5. Protein

6.3.1.6. Chemical

6.3.1.7. Others

6.3.2. Non-cargo

6.4. Market Attractiveness Analysis, by Exosome Type

7. Global Exosome Technologies Market Analysis and Forecast, by Cell Source

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Market Value Forecast, by Cell Source, 2015-2031

7.2.1. HEK293

7.2.2. MSCs

7.2.3. Platelets

7.2.4. Erythrocytes

7.2.5. Natural Killer Cells (NKs)

7.2.6. Others

7.3. Market Attractiveness Analysis, by Cell Source

8. Global Exosome Technologies Market Analysis and Forecast, by Indication

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Market Value Forecast, by Indication, 2015-2031

8.2.1. Therapeutics

8.2.1.1. Oncology

8.2.1.2. Neurodegenerative Diseases

8.2.1.3. Cardiovascular Diseases

8.2.1.4. Infectious Diseases

8.2.1.5. Cosmetics

8.2.1.6. Others

8.2.2. Diagnostics

8.3. Market Attractiveness Analysis, by Indication

9. Global Exosome Technologies Market Analysis and Forecast, by End-user

9.1. Introduction & Definition

9.1.1. Key Findings / Developments

9.2. Market Value Forecast, by End-user, 2015-2031

9.2.1. Health Care Providers

9.2.2. Pharmaceutical & Biotechnology Companies

9.2.3. Others

9.3. Market Attractiveness Analysis, by End-user

10. Global Exosome Technologies Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. Market Attractiveness Analysis, by Country/Region

11. North America Exosome Technologies Market Analysis and Forecast

12. Europe Exosome Technologies Market Analysis and Forecast

13. Asia Pacific Exosome Technologies Market Analysis and Forecast

14. Latin America Exosome Technologies Market Analysis and Forecast

15. Middle East & Africa Exosome Technologies Market Analysis and Forecast

16. Competition Landscape

• Aegle Therapeutics
• Anjarium Biosciences
• Aruna Biomedical
• Carmine Therapeutics
• Ciloa SAS
• Codiak BioSciences
• Creative Biolabs
• Danaher Corporation (Beckman Coulter)
• Direct Biologics
• Evercyte
• Evox Therapeutics
• ExoCan Healthcare Technologies Pvt. Ltd.
• ExoCoBio
• ExonanoRNA LLC
• Exopharm
• Exosome Diagnostics, Inc. (BIO-TECHNE CORPORATION)
• Fujifilm
• ILIAS Biologics, Inc.
• Illumina, Inc.
• Invitrix Therapeutics
• XOStem, Inc.
• VivaZome Therapeutics Pty Ltd.
• Thermo Fisher Scientific, Inc.
• Organicell
• OmniSpirant Ltd.
• Novadip Biosciences
• MDimune Inc.
• Lonza
• Kimera Labs
• QIAGEN
• Takara Bio, Inc.
• Tavec Pharma

For more information about this report visit https://www.researchandmarkets.com/r/9tfg1k

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900